Expertise in
13
conditions

Dr. Kenneth Kalunian

Rheumatology
UC San Diego Health Clinical Laboratory-La Jolla
9350 Campus Point Dr, 
La Jolla, CA 
Offers Telehealth
Expertise in
13
conditions
UC San Diego Health Clinical Laboratory-La Jolla
9350 Campus Point Dr, 
La Jolla, CA 

Overview

Kenneth Kalunian is a Rheumatologist in La Jolla, California. Dr. Kalunian is highly rated in 13 conditions, according to our data. His top areas of expertise are Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Cutaneous Lupus Erythematosus (CLE), Synovectomy, and Endoscopy.

His clinical research consists of co-authoring 150 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Rheumatology

Licenses

Internal Medicine in CA

Hospital Affiliations

Uc San Diego Health Hillcrest - Hillcrest Med Ctr

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

UC San Diego Health Clinical Laboratory-La Jolla
9350 Campus Point Dr, La Jolla, CA 92037
Other Locations
UC San Diego
200 W Arbor Dr, San Diego, CA 92103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
A Phase II Controlled Trial of Allogeneic Mesenchymal Stem Cells for the Treatment of Refractory Lupus
Enrollment Status: Completed
Publish Date: February 05, 2026
Intervention Type: Drug
Study Drugs: Low Dose Mesenchymal Stem Cells, High Dose Mesenchymal Stem Cells
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
A Phase 2, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101 in Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 18, 2022
Intervention Type: Drug
Study Drug: JBT-101
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
An Investigator-Initiated, Phase II, Randomized, Withdrawal Study of Mycophenolate Mofetil (MMF) in Patients With Stable, Quiescent Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: August 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

150 Total Publications

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC Study.
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 31, 2025
Similar Doctors
Expertise in
3
conditions
Dr. Robert Terkeltaub
Rheumatology
Expertise in
3
conditions
Dr. Robert Terkeltaub
Rheumatology

Jennifer Moreno Department Of Veterans Affairs Medical Center

3350 La Jolla Village Dr, 
San Diego, CA 
 (9.2 miles away)
858-552-8585
Languages Spoken:
English

Robert Terkeltaub is a Rheumatologist in San Diego, California. Dr. Terkeltaub is highly rated in 3 conditions, according to our data. His top areas of expertise are Gout, Arthritis, Calcium Pyrophosphate Arthritis, and Neonatal Onset Multisystem Inflammatory Disease.

Expertise in
4
conditions
Dr. Paul Aisen
Rheumatology
Expertise in
4
conditions
Dr. Paul Aisen
Rheumatology

Office

200 W Arbor Dr # 949, 
San Diego, CA 
 (0.5 miles away)
858-622-2028
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Paul Aisen is a Rheumatologist in San Diego, California. Dr. Aisen is highly rated in 4 conditions, according to our data. His top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Memory Loss. Dr. Aisen is currently accepting new patients.

Expertise in
4
conditions
Dr. Gary Firestein
Rheumatology
Expertise in
4
conditions
Dr. Gary Firestein
Rheumatology

UCSD Medical Offices South Pharmacy

4168 Front St, 
San Diego, CA 
 (0.1 miles away)
619-543-6248
Languages Spoken:
English
See accepted insurances

Gary Firestein is a Rheumatologist in San Diego, California. Dr. Firestein is highly rated in 4 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Vasculitis, Synovitis, and Tissue Biopsy.

Frequently Asked Questions about Dr. Kenneth Kalunian

How do I make an appointment with Dr. Kenneth Kalunian?

You can book an appointment with Dr. Kenneth Kalunian by calling their office at 858-657-6110. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kenneth Kalunian a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kenneth Kalunian is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kenneth Kalunian specialize in?

While Dr. Kenneth Kalunian is a Rheumatology, they have specific expertise in Systemic Lupus Erythematosus (SLE), Lupus Nephritis, and Cutaneous Lupus Erythematosus (CLE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Kenneth Kalunian participate in research or clinical trials?

Yes. Dr. Kenneth Kalunian has published 150 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Dr. Kenneth Kalunian's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kenneth Kalunian accept my insurance?

Dr. Kenneth Kalunian accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 858-657-6110 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kalunian's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile